Download PDFPDF

Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Myoclonus & Sub-acute Scerosing Pan Encephalitis
    • Jayendra R Gohil, Associate Professor Pediatrics
    • Other Contributors:
      • Sucheta Munshi, Jatin Mistry, Chirag Shah

    Dear Editor

    The differential diagnosis of JME should have mentioned specifically Sub-acute Scerosing Pan Encephalitis (SSPE), although progressive myoclonic epilepsies have been mentioned. SSPE occurs in India as measles still occurs and the age for first symptom of SSPE is similar to that of JME. SSPE carries a poor prognosis but JME responds to sodium valproate.

    The diagnosis of SSPE is based in clin...

    Show More
    Conflict of Interest:
    None declared.